Free Trial

QT Imaging (QTI) Competitors

QT Imaging logo
$2.55 +0.15 (+6.25%)
As of 09/12/2025

QTI vs. CATX, TLSI, OM, SI, MGRM, NNOX, INGN, STIM, ELMD, and INFU

Should you be buying QT Imaging stock or one of its competitors? The main competitors of QT Imaging include Perspective Therapeutics (CATX), TriSalus Life Sciences (TLSI), Outset Medical (OM), Shoulder Innovations (SI), Monogram Orthopaedics (MGRM), Nano-X Imaging (NNOX), Inogen (INGN), Neuronetics (STIM), Electromed (ELMD), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.

QT Imaging vs. Its Competitors

QT Imaging (NASDAQ:QTI) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Perspective Therapeutics has a consensus target price of $12.56, indicating a potential upside of 249.74%. Given Perspective Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Perspective Therapeutics is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Perspective Therapeutics
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
3 Strong Buy rating(s)
3.18

24.2% of QT Imaging shares are held by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are held by institutional investors. 75.4% of QT Imaging shares are held by insiders. Comparatively, 3.7% of Perspective Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

QT Imaging has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. QT Imaging's return on equity of 0.00% beat Perspective Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
Perspective Therapeutics -4,096.66%-27.40%-23.16%

QT Imaging has higher revenue and earnings than Perspective Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M17.31-$4.03MN/AN/A
Perspective TherapeuticsN/AN/A-$46.51MN/AN/A

In the previous week, Perspective Therapeutics had 3 more articles in the media than QT Imaging. MarketBeat recorded 3 mentions for Perspective Therapeutics and 0 mentions for QT Imaging. Perspective Therapeutics' average media sentiment score of 1.76 beat QT Imaging's score of 0.00 indicating that Perspective Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
QT Imaging Neutral
Perspective Therapeutics Very Positive

Summary

Perspective Therapeutics beats QT Imaging on 9 of the 14 factors compared between the two stocks.

Get QT Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for QTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

QTI vs. The Competition

MetricQT ImagingElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$69.19M$44.62M$5.79B$10.18B
Dividend YieldN/AN/A5.73%4.61%
P/E RatioN/A4.1374.8626.40
Price / Sales17.31221.20543.29125.95
Price / CashN/A41.3625.8129.91
Price / Book-1.342.5313.256.28
Net Income-$4.03M-$2.66M$3.29B$270.38M
7 Day Performance2.82%-0.62%0.47%2.70%
1 Month Performance27.50%14.22%4.60%5.99%
1 Year Performance388.04%226.40%73.42%25.94%

QT Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
QTI
QT Imaging
N/A$2.55
+6.3%
N/A+388.0%$69.19M$4.00M0.00N/A
CATX
Perspective Therapeutics
2.1354 of 5 stars
$3.37
-1.7%
$12.56
+272.6%
-77.0%$250.27MN/A0.0070Positive News
TLSI
TriSalus Life Sciences
3.0973 of 5 stars
$4.90
-2.2%
$10.75
+119.4%
-2.0%$249.84M$29.43M-4.15106
OM
Outset Medical
2.1252 of 5 stars
$14.19
+2.8%
$24.67
+73.8%
+72.2%$245.35M$113.69M-0.70520
SI
Shoulder Innovations
3.3186 of 5 stars
$14.87
-6.5%
$19.60
+31.8%
N/A$242.13MN/A-0.5061News Coverage
Analyst Upgrade
High Trading Volume
MGRM
Monogram Orthopaedics
1.7724 of 5 stars
$5.77
+0.3%
$5.40
-6.4%
+75.3%$233.64M$370K-11.5428Short Interest ↓
NNOX
Nano-X Imaging
2.9601 of 5 stars
$3.99
-0.7%
$8.50
+113.0%
-38.3%$232.27M$11.28M-4.43190
INGN
Inogen
4.0987 of 5 stars
$8.53
+0.9%
$11.00
+29.0%
-24.6%$228.49M$335.70M-8.051,030Positive News
STIM
Neuronetics
2.0262 of 5 stars
$3.69
+9.5%
$7.00
+89.7%
+328.2%$222.84M$111.11M-3.27180Positive News
ELMD
Electromed
3.993 of 5 stars
$26.61
+6.6%
$36.25
+36.2%
+31.0%$222.17M$64M35.48160News Coverage
Insider Trade
INFU
InfuSystem
3.1113 of 5 stars
$10.42
+1.6%
$12.50
+20.0%
+53.5%$212.84M$139.89M173.70410Positive News

Related Companies and Tools


This page (NASDAQ:QTI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners